<p>Mucoadhesive vaginal contraceptive film incorporating pyrrolidinium pyrrolidinium pyrrolidine-1-carbodithioate (PPC) as active ingredient.</p
The main objective of research work is to develophybrid mucoadhesive drug delivery systems for oral ...
Women are the most affected by genital herpes, which is one of the most common sexually transmitted ...
Gels containing chlorhexidine, based on hydroxyethylcellulose or its mixtures with either hydroxypro...
<p>Pyrrolidinium pyrrolidine-1-carbodithioate (PPC) release from mucoadhesive vaginal contraceptive ...
<p>PEG-400 was used as a solubilizer and plasticizer at a final concentration of 2.25 to 5.64%.</p
<p>(Mean ± SE of 3 independent experiments; MEC = minimum effective concentration; MIC = minimum inh...
The present research indicates fabrication of an “economic” controlled release bioadhesive vaginal t...
Novel formulations of vaginal bioadhesive tablets were prepared where the natamycin was complexed wi...
The purpose of this work was to design and evaluate a vaginal film delivery system for UAMC01398, a ...
Single-layer film for active ingredients dermal and transdermal administration containing at least a...
Purpose: Alternate formulation strategies need to be devised for improving the absorption and bioava...
The strategies for developing vaginal microbicides to protect women against human immunodeficiency v...
Rational design of vaginal drug delivery formulations requires special attention to vehicle properti...
The purpose of this work was to design and evaluate a novel vaginal delivery system for the local tr...
WOS: 000294516400006PubMed ID: 21804238The main objective of this work was to develop antifungal mat...
The main objective of research work is to develophybrid mucoadhesive drug delivery systems for oral ...
Women are the most affected by genital herpes, which is one of the most common sexually transmitted ...
Gels containing chlorhexidine, based on hydroxyethylcellulose or its mixtures with either hydroxypro...
<p>Pyrrolidinium pyrrolidine-1-carbodithioate (PPC) release from mucoadhesive vaginal contraceptive ...
<p>PEG-400 was used as a solubilizer and plasticizer at a final concentration of 2.25 to 5.64%.</p
<p>(Mean ± SE of 3 independent experiments; MEC = minimum effective concentration; MIC = minimum inh...
The present research indicates fabrication of an “economic” controlled release bioadhesive vaginal t...
Novel formulations of vaginal bioadhesive tablets were prepared where the natamycin was complexed wi...
The purpose of this work was to design and evaluate a vaginal film delivery system for UAMC01398, a ...
Single-layer film for active ingredients dermal and transdermal administration containing at least a...
Purpose: Alternate formulation strategies need to be devised for improving the absorption and bioava...
The strategies for developing vaginal microbicides to protect women against human immunodeficiency v...
Rational design of vaginal drug delivery formulations requires special attention to vehicle properti...
The purpose of this work was to design and evaluate a novel vaginal delivery system for the local tr...
WOS: 000294516400006PubMed ID: 21804238The main objective of this work was to develop antifungal mat...
The main objective of research work is to develophybrid mucoadhesive drug delivery systems for oral ...
Women are the most affected by genital herpes, which is one of the most common sexually transmitted ...
Gels containing chlorhexidine, based on hydroxyethylcellulose or its mixtures with either hydroxypro...